Avadel Pharmaceuticals (AVDL) Shares Outstanding (Diluted Average) (2016 - 2020)
Historic Shares Outstanding (Diluted Average) for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to $54.9 million.
- Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) rose 4688.93% to $54.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $54.9 million, marking a year-over-year increase of 4688.93%. This contributed to the annual value of $54.9 million for FY2020, which is 4688.93% up from last year.
- Per Avadel Pharmaceuticals' latest filing, its Shares Outstanding (Diluted Average) stood at $54.9 million for Q4 2020, which was up 4688.93% from $58.2 million recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $69.9 million in Q2 2020 and a low of $37.3 million during Q4 2018
- For the 5-year period, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) averaged around $43.1 million, with its median value being $41.2 million (2016).
- In the last 5 years, Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) skyrocketed by 10210057.99% in 2016 and then plummeted by 1163.4% in 2018.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $41.2 million in 2016, then grew by 1.25% to $41.8 million in 2017, then fell by 10.63% to $37.3 million in 2018, then rose by 0.21% to $37.4 million in 2019, then soared by 46.89% to $54.9 million in 2020.
- Its Shares Outstanding (Diluted Average) was $54.9 million in Q4 2020, compared to $58.2 million in Q3 2020 and $69.9 million in Q2 2020.